| Ytd | 0.00% | |
| 1y | 0.00% |
| Open | 6.00 | Prev Close | 6.00 | Low | 6.00 | High | 6.00 | Mkt Cap | 243.79M |
| Vol | 1.78M | Avg Vol | 409.63K | EPS | -0.50 | P/E | -12.00 | Forward P/E | -5.21 |
| Beta | 0.68 | Short Ratio | 3.00 | Inst. Own | 3.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-17 | 50-d Avg | 5.67 | 200-d Avg | 3.59 | 1yr Est | 5.00 |
Monogram Technologies Inc. (NASDAQ:MGRM ) Shareholder/Analyst Call September 30, 2025 1:00 PM EDT Co
Second quarter net sales of $2.077 billion increased 7.0% on a reported basis, 5.4% on a constant cu
The Procedure Utilized Monogram's mBôs TKA System Performed in India with Shalby Hospitals Groundbre
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
MONSEY, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigatin
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Monogram (NASDAQ: MGRM) for possible bre
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and naviga
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navig
AUSTIN, TEXAS / ACCESS Newswire / July 8, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram
Monogram Technologies Inc. (NASDAQ:MGRM ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET C
Receives FDA Clearance for the mBôs™ TKA System Groundbreaking Trial Set to Deliver one of the World
AUSTIN, TX / ACCESS Newswire / May 6, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or
Monogram Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation Patient En
Patient Enrollment will Begin Shortly; First Live Patient Surgeries are Anticipated within 90 Busine
AUSTIN, TX / ACCESS Newswire / March 20, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram"
Monogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food,
Monogram Technologies Inc. (NASDAQ:MGRM ) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET
This Press Release is Acting as a Correction to the Financial Tables in the Previous Release Complet
Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Inf
On Monday, 369 companies set new 52-week lows.
During Tuesday's session, 275 companies made new 52-week lows.
During Wednesday's session, 212 companies made new 52-week lows.
On Thursday, 221 companies hit new 52-week lows.